Evolus Share Price

Evolus Share Price

NASDAQ: EOLS | Small Cap | Healthcare
$6.51
-$0.52 (-7.33%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Evolus Stock Performance

Open
$7.08
Prev. Close
$7.03
Circuit Range
N/A
Day Range
$6.50 - $7.17
Year Range
$3.86 - $9.30
Volume
26,594
Average Traded
$6.78

Evolus Share Price Today

As of 21 November 2026, Evolus, Inc.'s share price is $6.51. The stock opened at $7.08, compared to its previous close of $7.03. During today's trading session, Evolus, Inc.'s share price traded between $6.50 and $7.17, with an average price of $6.84. Over the past 52 weeks, the stock has recorded a high of $9.30 and a low of $3.86. In terms of performance, Evolus, Inc.'s share price has declined by 0.76% over the last six months and is down 8.82% on a year-on-year basis.

Evolus Share Price Chart

Line chart of the Evolus price trend over the selected period. The price fell overall, ranging from 6.50 to 7.17, ending at 6.51.
$6.50$7.17
L
Show Current Price
H

Evolus Stock Fundamentals & Key Indicators

Market Cap
$419.69M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.47
Revenue (TTM)
$297.18B
Return On Equity (TTM)
82.28%
Profit Margin
-17.38%
Debt to Equity
-4.50
Quarterly Earnings Growth YoY
-9730.77%

Evolus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$90.30$73.14$84.08$77.95
Net Profit$0.13-$10.67-$8.05-$12.52
Net Profit Margin0.14%-14.59%-9.57%-16.06%
Income ChangeN/A-8307.69%24.55%-55.53%

Evolus Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$148.62$202.09$266.27$297.18
Net Profit-$74.41-$61.69-$50.42-$51.64
Net Profit Margin-50.07%-30.53%-18.94%-17.38%
Income ChangeN/A17.09%18.27%-2.42%

Evolus Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets82.9581.2376.5877.18
Current Assets142.92151.34112.42100.8
Total Assets225.87232.57189.0177.98
Non Current Liabilities173.67164.09161.4112.98
Current Liabilities75.3162.9648.2946.51
Total Liabilities248.97227.05209.69159.48
Shareholders' Equity-23.115.52-20.6918.5

Evolus Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-42.27-18.0-34.01-84.91
Investing-8.45-4.82-1.63-2.94
Financing17.3447.4144.64-4.15

About Evolus

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Evolus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.34
$6.51
-11.36%
Oct 2026
$7.98
$7.35
-8.24%
Sep 2026
$9.08
$8.01
-9.85%
Aug 2026
$5.88
$8.88
+51.88%
Jul 2026
$7.05
$5.85
-15.65%
Jun 2026
$6.53
$6.93
+5.72%
May 2026
$5.27
$6.56
+21.48%
Apr 2026
$4.11
$5.40
+31.39%
Mar 2026
$4.24
$4.11
-4.64%
Feb 2026
$4.69
$4.31
-7.91%
Jan 2026
$6.71
$4.68
-29.73%
Dec 2025
$7.04
$6.66
-6.72%

Evolus Share Price FAQs